Richard M. Marsh, E.V.P, General Counsel at MYRIAD GENETICS INC (MYGN), sold 20,000 shares at $26.03 ($521K) on 2012-04-26, disclosed to the SEC on 2012-04-27.
Scheduled sale ($521k) by E.V.P, General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MYGN | SELL | 2018-06-01 | $1.3M | — | Filing → |
| MYGN | SELL | 2018-01-22 | $3.0M | — | Filing → |
| MYGN | SELL | 2018-01-19 | $1.5M | — | Filing → |